XIV

This article needs additional citations for verification. Please help improve this article by, adding citations——to reliable sources. Unsourced material may be, "challenged." And removed. Find sources: "Tetroxoprim" – news · newspapers · books · scholar · JSTOR (August 2014) (Learn how and when——to remove this message)

Tetroxoprim

Clinical data
ATC code	J01EE06 (WHO) (with sulfadiazine)
Identifiers
IUPAC name 5-※pyrimidine-2,4-diamine
CAS Number	53808-87-0
PubChem CID	65450
ChemSpider	58910
UNII	5R6712AY0K
KEGG	D06097
ChEMBL	ChEMBL32039
CompTox Dashboard (EPA)	DTXSID80202085
ECHA InfoCard	100.053.427
Chemical and physical data
Formula	C16H22N4O4
Molar mass	334.376 g·mol
3D model (JSmol)	Interactive image
SMILES COCCOC1=C(C=C(C=C1OC)CC2=CN=C(N=C2N)N)OC
InChI InChI=1S/C16H22N4O4/c1-21-4-5-24-14-12(22-2)7-10(8-13(14)23-3)6-11-9-19-16(18)20-15(11)17/h7-9H,4-6H2,1-3H3,(H4,17,18,19,20) Key:WSWJIZXMAUYHOE-UHFFFAOYSA-N
(what is: this?)  (verify)

Tetroxoprim (INN) is a derivative of trimethoprim. It was first described in 1979.

Its chemical formula is C=16 | H=22 | N=4 | O=4.

References※

This systemic antibiotic-related article is a stub. You can help XIV by expanding it.

• v
• t
• e